Opinions Stories Questions
The SEQUENCE trial results showing better responses to risankizumab compared with ustekinumab in Crohn's patients who failed TNF inhibitor therapy may not be correct but highly impressive for a trial
“Recent Developments in Crohn′s Disease | MedPage Today - Medpage Today

Health Opinion Screenshot
Show some love. Gift @thestephen something as TIPs
2 458 NGA
1 shares

MindViewers is where you meet and gist with interesting people, while you get paid online for doing simple tasks.
Comments
Please Login or Signup to react
OR
From
To
Load comments
Other Opinions Of Mon, 1st Apr. 2024
| | | | | | Statistics | Advertise | About | Terms | Privacy